Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
86.45
+7.02 (8.84%)
Nov 20, 2024, 4:00 PM EST - Market closed
Lantheus Holdings Market Cap
Lantheus Holdings has a market cap or net worth of $6.01 billion as of November 21, 2024. Its market cap has increased by 36.23% in one year.
Market Cap
6.01B
Enterprise Value
5.77B
1-Year Change
36.23%
Ranking
Category
Stock Price
$86.45
Market Cap Chart
Since June 25, 2015, Lantheus Holdings's market cap has increased from $178.90M to $6.01B, an increase of 3,259.75%. That is a compound annual growth rate of 45.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 5.52B | 30.05% |
Dec 29, 2023 | 4.25B | 21.06% |
Dec 30, 2022 | 3.51B | 79.37% |
Dec 31, 2021 | 1.96B | 116.78% |
Dec 31, 2020 | 902.10M | 12.06% |
Dec 31, 2019 | 805.00M | 33.72% |
Dec 31, 2018 | 602.00M | -21.51% |
Dec 29, 2017 | 767.00M | 149.67% |
Dec 30, 2016 | 307.20M | 188.72% |
Dec 31, 2015 | 106.40M | -40.53% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Blueprint Medicines | 5.73B |
Corcept Therapeutics | 5.51B |
Viking Therapeutics | 5.47B |
Halozyme Therapeutics | 5.42B |
Ionis Pharmaceuticals | 5.33B |
Inspire Medical Systems | 5.25B |
Waystar Holding | 5.23B |
Krystal Biotech | 5.05B |